Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-05-17
Original SEC Filing: Click here

---

Webplus: BSPM/20100517/8-K_1/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS XIANYANG, China, May 17, 2010 (Xinhua-PRNewswire-FirstCall) – Q1 2010 revenue increased 66.0% to $12.4 million – Q1 gross margins were 77.0%, a 1,270-basis point improvement – Q1 2010 Non-GAAP adjusted net income increased 32.1% to $2.4 million with adjusted EPS of $0.09 – Biostar reiterates guidance for 2010: Revenue expected to

---

---

Webplus: BSPM/20100517/8-K_1/1/000.htm SEC Original: biostarpharma8k051710.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): May 17, 2010 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-05-17CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046